Highlights from 2024 NEI Synapse: Memories in the Future: An Update on the Diagnosis and Treatment of Alzheimer’s Disease
April 18, 2024
In her 2024 NEI Synapse presentation, Dr. Dani Cabral enlightened t...
Read More
Erectile Dysfunction Drugs May Protect Against Alzheimer’s
March 3, 2024
With Alzheimer’s disease (AD) cases projected to reach 157 million ...
Read More
Blood Test Predicts Who Might Benefit Most From Anti-Amyloid Drugs
January 9, 2024
The widely accepted Amyloid Cascade Hypothesis indicates that the m...
Read More
Gut Microbiome Composition May be an Indicator of Preclinical Alzheimer’s Disease
June 23, 2023
With Alzheimer’s disease (AD) becoming a global crisis, as lifespan...
Read More
Sleep-Disordered Breathing Tied to Brain Volumes in Amyloid-Positive Older Adults
June 19, 2023
Sleep-disordered breathing (SDB) has been associated with increased...
Read More
FDA Approves First Treatment for Agitation Associated with Alzheimer’s Dementia
May 10, 2023
The U.S. Food and Drug Administration (FDA) has approved the supple...
Read More
Blood Test Predicts Which People With Amyloid Are Likely to Decline Cognitively
March 1, 2023
The pathology of Alzheimer’s disease (AD) begins with a prolonged p...
Read More
The Future of Psychopharmacology
February 9, 2023
It is an incredible time in terms of the development of new psychop...
Read More
FDA Grants Accelerated Approval for Alzheimer’s Disease Treatment
January 23, 2023
The U.S. Food and Drug Administration recently approved lecanemab, ...
Read More
'Convincing Evidence' Hearing Aids Reduce Dementia Risk
December 20, 2022
With no truly effective treatment for dementia yet available, there...
Read More
Highlights from 2022 NEI Congress: Management of Agitation Associated With Alzheimer’s Dementia
November 6, 2022
When a patient presents with agitation it represents a substantial ...
Read More
Alzheimer's Awareness Month
November 1, 2022
October is ADHD Awareness Month. The goal of ADHD Awareness Month i...
Read More